Plasma Volume Oscillations During Intravenous Infusion of Hyper-Oncotic Albumin

Low-frequency oscillations of blood components have been observed when the plasma is diluted by crystalloid fluid. The present study explores whether oscillations also occur during the infusion of hyper-oncotic albumin 20%. For this purpose, the hemoglobin-derived plasma dilution, plasma colloid osmotic pressure, and plasma albumin concentration were measured on 15 occasions over 5 h in 72 volunteers. All of them received 3 mL/kg of albumin 20% over 30 min in various clinical settings. Quality checks excluded 35% of the concentration-time curves, leaving 137 for analysis. Fourier transforms applied to the residuals after curve-fitting showed that the dominating frequency was 144 ± 42 min (mean ± SD), corresponding to 0.007 Hz and a wave amplitude of 1.8 ± 0.9%. The highest percentile of the amplitudes corresponded to a "peak-to-peak" variation in the plasma volume by 6%, which corresponds to a fluctuation of 180 mL, or 45% of the maximum volume expansion following the infusion of albumin 20%. Differences between settings (volunteers, surgery, postoperative, and post-burn) were small. In conclusion, oscillations with very low frequency occurred after infusion of albumin 20%. They varied the plasma volume by 3.6% and by up to 6% in the percentile with the highest amplitudes. The oscillations are large enough to affect measurements of cardiovascular function.

Authors

Institutions

Publication Details

Journal
Life
Published
2025-05-07
DOI
https://doi.org/10.3390/life15050749
Primary Topic
Hemodynamic Monitoring and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma Volume Oscillations During Intravenous Infusion of Hyper-Oncotic Albumin

Robert G. Hahn
Life
Hemodynamic Monitoring and Therapy
article

Plasma Volume Oscillations During Intravenous Infusion of Hyper-Oncotic Albumin

Robert G. Hahn
article en

Abstract

Low-frequency oscillations of blood components have been observed when the plasma is diluted by crystalloid fluid. The present study explores whether oscillations also occur during the infusion of hyper-oncotic albumin 20%. For this purpose, the hemoglobin-derived plasma dilution, plasma colloid osmotic pressure, and plasma albumin concentration were measured on 15 occasions over 5 h in 72 volunteers. All of them received 3 mL/kg of albumin 20% over 30 min in various clinical settings. Quality checks excluded 35% of the concentration-time curves, leaving 137 for analysis. Fourier transforms applied to the residuals after curve-fitting showed that the dominating frequency was 144 ± 42 min (mean ± SD), corresponding to 0.007 Hz and a wave amplitude of 1.8 ± 0.9%. The highest percentile of the amplitudes corresponded to a "peak-to-peak" variation in the plasma volume by 6%, which corresponds to a fluctuation of 180 mL, or 45% of the maximum volume expansion following the infusion of albumin 20%. Differences between settings (volunteers, surgery, postoperative, and post-burn) were small. In conclusion, oscillations with very low frequency occurred after infusion of albumin 20%. They varied the plasma volume by 3.6% and by up to 6% in the percentile with the highest amplitudes. The oscillations are large enough to affect measurements of cardiovascular function.

LifeVol. 15(5)
Karolinska Institutet (SE)
Good health and well-being
Openalex Percentile: Top 83%
Hemodynamic Monitoring and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Plasma Volume Oscillations During Intravenous Infusion of Hyper-Oncotic Albumin — Robert G. Hahn · Life (2025) | TGRS Research Map | TGRS